In April 2018, in time for IBS Awareness Month, the Gastrointestinal Society in Canada released a 38 page 2018 IBS Global Impact Report, which is available for download on its website.  This report was funded and facilitated by the international pharmaceutical company Allergan, and overseen by a steering committee composed of Maura Corsetti, MD of the University of Nottingham in the United Kingdom, Jan Tack, MD of the University of Leuven in Belgium, Gail Attara, President and CEO of the Gastrointestinal Society, and Michelle Sewell, IBS support group representative for the Gastrointestinal Society. The report incorporated  peer-reviewed literature and surveys of people with IBS and families in numerous countries, including Canada, the United States, Australia and Spain over the last several years, and made recommendations accordingly. Some of this data was drawn from the Gastrointestinal Society’s own 2016 national survey across Canada of adults with IBS and parents of children with IBS.

Posted: May 2018